AI strategy and governance for life sciences, built to produce reusable precedent rather than another approval gate.
Ask a large life sciences organization how many AI initiatives it has and the answer is usually a number nobody is confident about. Ask how many have been stopped and the answer is almost always close to none. Pilots in this industry do not fail; they go quiet. The sponsor moves roles, the enthusiasm shifts to a newer technique, the budget is not renewed and nothing is ever formally concluded, so the initiative remains nominally alive and the learning from it is never captured. Meanwhile the next project starts its governance conversation from the beginning, because whatever was agreed for the last one was agreed as a one-off and never written as a pattern.
Two failures compound each other. The first is that the portfolio has no exit mechanism. Stopping an initiative requires somebody to say it is not working, which attracts attention, disappoints a sponsor and offers no reward, while allowing it to continue quietly costs that person nothing. So initiatives accumulate rather than resolve, the organization cannot say what it has or what any of it is delivering, and capacity is consumed by work nobody has decided to continue.
The second is that nothing becomes reusable. When a project finally obtains an approval from quality, the approval is for that project: this model, this use, this data, this time. The reasoning is not captured as a method, the risk classification is not written as a scheme, and the controls are not published as a pattern. The next team therefore starts the same conversation with the same functions, who are being asked to make the same judgement again with no record of how they made it last time. After three or four cycles the organization has considerable AI experience and no accumulated governance capital, which is why the fifth project takes as long as the first and why quality colleagues become steadily more cautious rather than more comfortable.
Nobody is rewarded for stopping something
So initiatives go quiet instead of ending, and the portfolio only ever grows.
Approvals are granted per project, not as patterns
The reasoning is never captured, so the next team renegotiates from the beginning.
Data readiness is assessed after the use case is chosen
Which is the wrong order, and it is where most of the delay actually comes from.
Governance is designed as a gate
A uniform checkpoint slows everything equally and scrutinises nothing in particular.
Value is claimed in hours saved and never measured
So nobody can distinguish the initiatives that worked from the ones that were enjoyable.
The regulatory position is moving
And frameworks written to encode this year’s rules will need rewriting rather than extending.
Count how many AI initiatives you have, then count how many you have ever stopped. The first number is usually larger than expected and difficult to establish, which is itself the finding. The second is almost always close to zero, in a field where a high failure rate is normal and expected. An organization that has run twenty initiatives and concluded none of them is not succeeding at twenty things, it is carrying nineteen it has not evaluated. Establishing those two numbers takes a week, requires no technology, and reframes the strategy conversation more effectively than any maturity assessment.
The first governed deployment is expensive and should be treated as an investment in a reusable asset rather than as a project. Everything that made it approvable, the classification, the controls, the evidence, the review model, is captured as a pattern so the second one inherits it. That is the whole mechanism by which an AI programme becomes cheaper over time rather than more cautious.
Step 1
Inventory what exists and what it is producing
Step 2
Stop things, deliberately and visibly
Step 3
Score candidates on data readiness as a gate
Step 4
Define the risk classification scheme
Step 5
Get the scheme approved at the right level
Step 6
Deliver the first case through the scheme
Step 7
Capture everything reusable from it
Step 8
Build the platform controls that enforce the scheme
Step 9
Define the operating model and who owns what
Step 10
Measure value where it lands, not where it was promised
Governance exists to make the second project cheap. Judge any governance framework by one question: after the first deployment goes through it, is the next one materially faster. If every initiative requires the same depth of review, the same novel risk assessment and the same negotiation with quality, then what exists is an approval process rather than governance, and it will grow more cautious over time as the people in it accumulate exposure without accumulating precedent. Real governance converts a decision made once into a condition that many subsequent projects simply satisfy.
Every item below is scoped to produce something the organization keeps using: a scheme, a register, a control set, a template, a working platform capability. A strategy engagement that ends in a presentation has produced an opinion, and opinions do not survive the sponsor changing roles.
Strategy and portfolio
AI inventory across the organization, including the initiatives nobody is tracking, which is usually most of them
Data readiness assessment per candidate use case, scored as a gate rather than as a risk to be managed later
Use case prioritisation against consequence, data readiness, reusability and the capacity to actually deliver
Portfolio management with a stopping mechanism, since a portfolio nothing leaves is a list
Value measurement designed before delivery, because a baseline cannot be captured retrospectively
Roadmap sequenced so each delivery makes the next one cheaper rather than starting again
Governance and risk
Risk classification scheme by consequence and reversibility, with controls and approval routes defined per tier
Model risk management proportionate to tier, covering development, validation, deployment and retirement
Responsible AI position covering fairness, transparency, human oversight and the limits of each
Policy that is implementable, meaning every clause maps to a control somebody can actually enforce
Validation approach for probabilistic components, agreed with quality as a method rather than per project
Incident definition and response, including what constitutes an AI incident, which almost nobody has defined
Operating model and adoption
Operating model design across central capability and federated ownership, with decision rights written down
Roles and accountabilities, including who approves, who is consulted and who answers when something goes wrong
Capability building, since governance that depends on one person is a dependency rather than a function
Vendor and model provider assessment, which is a supplier process your quality system already has
Change management for the people whose work the technology affects, which determines adoption more than capability does
Regulatory monitoring, so the framework absorbs change rather than needing rewriting
The third column is the first thing to do in each function, chosen because it establishes the governance pattern on work where being wrong is recoverable. Starting with the highest-value regulated process is the most common sequencing error in this industry.
| Function | Where the pressure is | Where to start |
|---|---|---|
| Clinical operations | Study start-up time and document burden | Document completeness and classification, where errors are visible and cheap |
| Clinical data management | Query volume and listing review | Candidate discrepancy identification, with the data manager deciding |
| Regulatory affairs | Submission assembly and commitment tracking | Finding and reconciling content, with authoring left alone |
| Pharmacovigilance | Case volume against fixed deadlines | Intake structuring and duplicate detection, never determinations |
| Quality | Investigation effort and CAPA backlog | Evidence assembly before an investigation opens |
| Manufacturing and supply | Deviation paperwork and planning | Exception flagging and demand signal work, which is outside GxP scope |
| Laboratory operations | Instrument data handling and scheduling | The least regulated and most tractable starting point in most organizations |
| Commercial and medical | Content volume and field support | Approved-content assistants, with medical review unchanged |
The gap between a governance framework and a governed organization is entirely implementation. Each control below is the technical mechanism by which a written policy becomes a condition that holds whether or not anybody remembers it, which is the only form of governance that survives contact with delivery pressure.
| Control | What it enforces | Without it |
|---|---|---|
| AI gateway | All model traffic through one governed path | Shadow usage nobody can inventory, on terms nobody reviewed |
| Model registry | What is deployed, which version, approved for what use | Nobody can answer what is running, which is the first audit question |
| Inventory and classification | Every system tiered, with its controls attached | Risk tiering exists in a policy and nowhere in reality |
| Evaluation harness | Performance measured consistently and on change | Each team invents its own evidence and none of it compares |
| Prompt and config versioning | Behaviour-affecting changes under control | The system changes and the validation refers to something else |
| Observability | What was asked, retrieved, produced and approved | Incidents cannot be reconstructed and drift is invisible |
| Data access enforcement | Permissions applied at query time, per user | Governance depends on every application behaving correctly |
Ask what is in production, and see how long the answer takes. A functioning governance capability can produce, within minutes, a list of every AI system in production, its risk tier, its owner, when it was last evaluated and what it is approved to do. Most organizations cannot assemble that in a fortnight, and the assembly is manual and incomplete. That single request is the most efficient diagnostic available, because the inventory is both the simplest governance artifact and the one that only exists if the controls underneath it are real. An inspector or a customer auditor will ask the same question, and they will draw the same conclusion from how long it takes.
The frameworks below sit at different stages of maturity and are moving at different speeds. The established quality and privacy frameworks are stable and well understood. The AI-specific instruments are newer, their application to particular life sciences uses is still settling, and some of what is written about them today will be revised. A governance framework that encodes current interpretations will need rewriting; one built on an inventory, a classification scheme, documented reasoning and evidence will absorb change by adjusting what sits in each tier. Which obligations apply to your organization is a determination for your regulatory and legal functions, and this page deliberately asserts none.
Established frameworks
- GxP and GAMP 5 where the AI supports regulated activity, with assurance proportionate to use
- 21 CFR Part 11 and EU Annex 11 where records and signatures fall within scope
- ICH GCP for clinical activity, and ALCOA+ wherever AI contributes to a regulated record
- HIPAA and GDPR for personal data, which most life sciences AI touches somewhere
AI-specific instruments
- The EU AI Act, whose classification and obligations for specific uses your legal function determines
- NIST AI RMF as a voluntary framework many organizations adopt to structure their approach
- ISO/IEC 42001 as a management system standard, which suits organizations already operating certified systems
- Emerging regulator expectations on AI in regulated processes, which your regulatory function should be tracking
What survives regulatory change
- An inventory of what exists, which every framework assumes and few organizations have
- A classification scheme by consequence, which maps onto most instruments with adjustment rather than rewriting
- Documented reasoning for each decision, which is what any future framework will ask you to produce
- Evidence generated by the platform, since retrospective evidence is the expensive kind
Model risk
- Validation approach appropriate to probabilistic components, agreed as a method rather than per project
- Performance monitoring with defined action thresholds, since degradation is silent
- Provider change management, because a model updated by a vendor is a change to your system
- Retirement, which nobody plans and which is where dormant unmanaged systems come from
Governance attention concentrates almost entirely on getting a system approved, and the risk lives in the period afterwards, when the model changes, the data shifts, the usage broadens and the people who understood the original decision move on. The failure modes below are all post-approval and all silent.
| Failure | How it presents |
|---|---|
| Scope creeps after approval | The system is pointed at a second use nobody reassessed, because it works |
| A provider updates the model | Behaviour changes, no internal change was made, and nothing triggered a review |
| Oversight becomes nominal | Approval volume per reviewer is implausible and nobody has looked at the rate |
| The reviewer has no authority to stop it | Oversight exists on paper and the person reviewing cannot halt what they doubt |
| A vendor changes a service underneath you | An external update alters behaviour, performance or data handling with no notice |
| Running cost grows without an owner | Usage-priced consumption scales quietly until finance rather than governance raises it |
| The owner leaves | A system in production with no accountable person and no retirement decision |
| Evaluation was run once | Performance was established at acceptance and never since |
| An incident has no category | A wrong output caused harm and no process says what this is or who handles it |
| Usage drifts from the design | People use it for something adjacent, and the controls were scoped to the original |
| Shadow systems reappear | A governed path became slower than the ungoverned one, and behaviour followed |
AI strategy engagements are reported as roadmaps delivered and frameworks published. The outcome that matters is whether the organization now moves faster and more safely than it did, which shows up in two numbers: what the second deployment costs relative to the first, and how quickly anybody can say what is running.
| Category | What we measure | Why it matters |
|---|---|---|
| Cost of the second deployment | Effort and elapsed time relative to the first through the same scheme | The single clearest test of whether governance is producing precedent |
| Inventory completeness and currency | Time to produce a full list of production AI with tier and owner | The simplest governance artifact and the one that only exists if the controls are real |
| Initiatives concluded | Stopped deliberately, with the learning captured | A portfolio nothing leaves is a list, and this number is usually zero |
| Classification coverage | Proportion of systems with an assigned tier and attached controls | Governance that exists in a policy and not in the estate is not governance |
| Shadow usage trend | Ungoverned model usage, as the sanctioned path improves | Measures whether the governed route is genuinely better or merely mandated |
| Evaluation currency | Systems evaluated within their defined period | Performance established once at acceptance is not performance monitoring |
| Value realised against value claimed | Measured outcomes versus the business case | Separates initiatives that worked from ones that were enjoyable |
We will inventory what exists, help you stop what should stop, score candidates on data readiness before business value, build a classification scheme your leadership can approve once, deliver the first case through it, and leave you with a pattern the next five projects inherit.
CaliberFocus is a life sciences AI partner delivering strategy and governance designed to produce reusable precedent rather than another approval gate. From an AI inventory and portfolio decisions, including what to stop, to data readiness scoring, a risk classification scheme approved once at the right level and the platform controls that enforce it, we make every governed deployment cheaper than the one before.
- Governance designed to create precedent, not checkpoints
- Use cases scored on data readiness before commitment
- Risk classified by consequence, so most work moves fast
- Policy enforced through platform controls, not documents
Security & Compliance
